Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Frontiers in Immunology|May 27, 2024
Case report: Is severe toxicity the price to pay for high sensitivity to checkpoint inhibitors immunotherapy in desmoplastic melanoma?Teresa Squicciarini, Rossella Villani, Benedetta Apollonio, et al.
Scientific Reports|November 27, 2022
A deep learning model based on whole slide images to predict disease-free survival in cutaneous melanoma patientsMaria Colomba Comes, Livia Fucci, Fabio Mele, et al.
Frontiers in Oncology|October 4, 2021
Electrochemotherapy as a Trigger to Overcome Primary Resistance to Anti-PD-1 Treatment: A Case Report of Melanoma of the ScalpDavide Quaresmini, Alessandra Di Lauro, Livia Fucci, et al.
Expert Opinion on Therapeutic Targets|November 30, 2021
PD-L1 and Notch as novel biomarkers in pancreatic sarcomatoid carcinoma: a pilot studyNicola Silvestris, Antonella Argentiero, Oronzo Brunetti, et al.
Oncology Research|July 28, 2021
uPAR Controls Vasculogenic Mimicry Ability Expressed by Drug-Resistant Melanoma CellsElena Andreucci, Anna Laurenzana, Silvia Peppicelli, et al.
Cancers|October 17, 2019
The Management of Oligoprogression in the Landscape of New Therapies for Metastatic MelanomaMichele Guida, Nicola Bartolomeo, Ivana De Risi, et al.
Journal of Experimental & Clinical Cancer Research : CR|September 27, 2023
Circulating extracellular vesicles are monitoring biomarkers of anti-PD1 response and enhancer of tumor progression and immunosuppression in metastatic melanomaSimona Serratì, Roberta Di Fonte, Letizia Porcelli, et al.
Pharmacological Research|June 25, 2022
BRAFV600E;K601Q metastatic melanoma patient-derived organoids and docking analysis to predict the response to targeted therapyLetizia Porcelli, Roberta Di Fonte, Ciro L Pierri, et al.
Cancers|June 1, 2019
Molecular Characterization of a Long-Term Survivor Double Metastatic Non-Small Cell Lung Cancer and Pancreatic Ductal Adenocarcinoma Treated with Gefitinib in Combination with Gemcitabine Plus Nab-Paclitaxel and mFOLFOX6 as First and Second Line TherapyOronzo Brunetti, Giuseppe Badalamenti, Simona De Summa, et al.
Cancers|June 2, 2021
The Interaction between Reactive Peritoneal Mesothelial Cells and Tumor Cells via Extracellular Vesicles Facilitates Colorectal Cancer DisseminationSimona Serratì, Letizia Porcelli, Francesco Fragassi, et al.
Pageof 3